NODE PHARMA AS
0349 OSLO
Return on Equity
95,57Â %
Current Ratio
1,22
Debt-to-Equity Ratio
−1,46
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 1Â 313Â 000 | |
| Net Income | −582 000 | |
| Total Assets | 1Â 130Â 000 | |
| Total Equity | −609 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 1Â 313Â 000 | |
| Expenditure | 1Â 894Â 000 | |
| Operating Profit | −581 000 | |
| Financial Income | 1Â 000 | |
| Financial Costs | 1Â 000 | |
| Financial Balance | 0 | |
| Earnings Before Tax | −582 000 | |
| Tax | 0 | |
| Net Income | −582 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 88Â 000 | |
| Total Current Assets | 1Â 042Â 000 | |
| Total Assets | 1Â 130Â 000 | |
| Total Retained Equity | −643 000 | |
| Total Equity | −609 000 | |
| Total Long-Term Debt | 888Â 000 | |
| Total Current Debt | 851Â 000 | |
| Total Equity and Debt | 1Â 130Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 1Â 313Â 000 | |
| Other Income | 0 | |
| Revenue | 1Â 313Â 000 | |
| Cost of Goods Sold | 0 | |
| Salary Costs | 494Â 000 | |
| Depreciation | 0 | |
| Impairment | 0 | |
| Expenditure | 1Â 894Â 000 | |
| Operating Profit | −581 000 | |
| Financial Income | 1Â 000 | |
| Financial Costs | 1Â 000 | |
| Financial Balance | 0 | |
| Dividends | 0 | |
| Net Income | −582 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 0 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 88Â 000 | |
| Total Fixed Assets | 88Â 000 | |
| Stock | 0 | |
| Total Investments | 0 | |
| Cash, Bank | 438Â 000 | |
| Total Current Assets | 1Â 042Â 000 | |
| Total Assets | 1Â 130Â 000 | |
| Total Equity | −609 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 888Â 000 | |
| Creditors | 227Â 000 | |
| Unpaid Taxes | 86Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 539Â 000 | |
| Total Current Debt | 851Â 000 | |
| Total Equity and Debt | 1Â 130Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 95,57Â % | |
| Debt-to-Equity Ratio | −1,46 | |
| Operating Profit Margin | −44,25 % | |
| Current Ratio | 1,22 | |
| Quick Ratio | 1,22 | |
| Equity Ratio | −0,54 | |
| Gross Profit Margin | 100Â % |
Rotate your device to see the full table